| Validation of the NCCN‐IPI for diffuse large B‐cell lymphoma (DLBCL): the addition of β2‐microglobulin yields a more accurate GELTAMO‐IPI C Montalbán, A Díaz‐López, I Dlouhy, J Rovira, A Lopez‐Guillermo, ... British Journal of Haematology 176 (6), 918-928, 2017 | 99 | 2017 |
| WHO‐histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes A Alvarez‐Larrán, A Ancochea, M García, F Climent, F García‐Pallarols, ... British journal of haematology 166 (6), 911-919, 2014 | 82 | 2014 |
| Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group S Alonso‐Álvarez, L Magnano, M Alcoceba, M Andrade‐Campos, ... British journal of haematology 178 (5), 699-708, 2017 | 77 | 2017 |
| Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia A Alvarez-Larrán, A Ancochea, A Angona, C Pedro, F García-Pallarols, ... Haematologica 97 (11), 1704, 2012 | 75 | 2012 |
| NT-proBNP: a cardiac biomarker to assess prognosis in non-Hodgkin lymphoma E Gimeno, M Gómez, JR González, J Comín, A Alvarez-Larrán, ... Leukemia research 35 (6), 715-720, 2011 | 44 | 2011 |
| Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population L Magnano, S Alonso‐Alvarez, M Alcoceba, A Rivas‐Delgado, ... British Journal of Haematology 185 (3), 480-491, 2019 | 37 | 2019 |
| The role of serum erythropoietin level and jak2 v617f allele burden in the diagnosis of polycythaemia vera À Ancochea, A Álvarez‐Larrán, C Morales‐Indiano, F García‐Pallarols, ... British journal of haematology 167 (3), 411-417, 2014 | 37 | 2014 |
| Masked polycythaemia vera: presenting features, response to treatment and clinical outcomes A Alvarez‐Larrán, A Angona, A Ancochea, F García‐Pallarols, ... European journal of haematology 96 (1), 83-89, 2016 | 34 | 2016 |
| Intermediate dose of nonpegylated liposomal doxorubicin combination (R-CMyOP) as first line chemotherapy for frail elderly patients with aggressive lymphoma E Gimeno, B Sánchez-González, A Álvarez-Larrán, C Pedro, E Abella, ... Leukemia Research 35 (3), 358-362, 2011 | 24 | 2011 |
| Anthracycline‐induced cardiotoxicity in diffuse large B‐cell lymphoma: NT‐proBNP and cardiovascular score for risk stratification MP Ferraro, E Gimeno‐Vazquez, I Subirana, M Gómez, J Díaz, ... European Journal of Haematology 102 (6), 509-515, 2019 | 21 | 2019 |
| Do patients and physicians agree when they assess quality of life? A Barata, R Martino, I Gich, I García-Cadenas, E Abella, P Barba, ... Biology of Blood and Marrow Transplantation 23 (6), 1005-1010, 2017 | 19 | 2017 |
| Differential prognostic impact of GELTAMO‐IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm C Montalbán, A Díaz‐López, A Martín, M Baile, JM Sanchez, JM Sancho, ... British Journal of Haematology 182 (4), 534-541, 2018 | 10 | 2018 |
| Essential thrombocythemia: baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients A Angona, A Alvarez-Larrán, B Bellosillo, L Martínez-Avilés, ... Medicina Clínica (English Edition) 144 (6), 247-253, 2015 | 10 | 2015 |
| Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: a cross sectional study E Abella, E Pradenas, F Muñoz-Lopez, F Garcia-Pallarols, RBAB Lahsen, ... Life Science Alliance 5 (12), 2022 | 7 | 2022 |
| Study of the frequency and reasons for discontinuation of different lines of treatment in patients with multiple myeloma A Senín, F García-Pallarols, R Ben Azaiz, L Martínez-Serra, ... Annals of Hematology 98, 705-711, 2019 | 5 | 2019 |
| Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO)(2019) Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to … L Magnano, S Alonso-Alvarez, M Alcoceba, A Rivas-Delgado, ... Br J Haematol 185 (3), 480-491, 0 | 5 | |
| Trombocitemia esencial: características iniciales y factores de riesgo de supervivencia y trombosis en una serie de 214 pacientes A Angona, A Alvarez-Larrán, B Bellosillo, L Martínez-Avilés, ... Medicina Clínica 144 (6), 247-253, 2015 | 4 | 2015 |
| Assessment of cell-free dna (cfdna) in 221 patients with lymphoproliferative malignancies at diagnosis and during follow-up MM Andrade-Campos, A Salar, B Sanchez-Gonzalez, ... Blood 134, 492, 2019 | 3 | 2019 |
| Prognostic impact of anthracyclines in the treatment of aggressive lymphoma in patients over 70 years Á Ancochea, A Salar, F García-Pallarols, E Gimeno, ... Medicina Clínica (English Edition) 144 (12), 544-547, 2015 | 3 | 2015 |
| PF326 VITAMIN D INSUFFICIENCY AND PROGNOSIS IN LYMPHOMA B Sanchez-Gonzalez, J Platero, A Ortuño, F Garcia-Pallarols, S Perez, ... HemaSphere 3 (S1), 115-116, 2019 | 2 | 2019 |
